HRT Financial’s Universe Pharmaceuticals Inc UPC Stock Holding History

HRT Financial’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Buy	+16,902	New	+$54.9K	﹤0.01%	3607
2023 Q3	–	Sell	-5	Closed	-$6K	–	3131
2023 Q2	$6K	Buy	+5	New	+$10.8K	﹤0.01%	2220

Other funds holding UPC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's UPC Position: Q2 2026 in Review

HRT Financial opened a new position in Universe Pharmaceuticals Inc (UPC) in Q2 2026: 16,902 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #3607 among its holdings. This is a return to the name: HRT Financial previously reported a position in UPC as recently as Q2 2023.

HRT Financial first reported a position in UPC in Q2 2023 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold UPC as of Q2 2026.

HRT Financial held 16,902 shares of Universe Pharmaceuticals Inc worth $103K as of Q2 2026.
Universe Pharmaceuticals Inc was a new HRT Financial position in Q2 2026.
Universe Pharmaceuticals Inc made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3607 holding.
HRT Financial first reported a position in Universe Pharmaceuticals Inc in Q2 2023 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.